PBTF-Funded Models Advance PLGG Research

At the Pediatric Brain Tumor Foundation (PBTF), we believe every grant we fund should create ripple effects far beyond the initial project.

A powerful example is the groundbreaking work led by Dr. Corina Anastasaki at Washington University in St. Louis (WashU), supported through our partnership with the Pediatric Low-Grade Astrocytoma (PLGA) initiative.

Dr. Anastasaki has developed a vital repository of “living” models from children’s low-grade glioma (LGG) tumor samples, successfully establishing over 10 cell lines for two critical subtypes of these common childhood brain tumors. These models allow scientists to study how tumors grow and test new therapies in a way that closely mimics what happens in a child’s brain. This shared resource is already accelerating discoveries across the scientific community, amplifying the impact of a single grant to bring hope to countless families.

This work highlights the urgent need for high-quality models to develop safer, more effective treatments. As Dr. David H. Gutmann, Director of the Neurofibromatosis Center at Washington University, affirmed, this repository is a “pivotal advancement” made possible by PBTF’s support, representing a critical step forward in our fight against pediatric low-grade gliomas.

Dr. Anastasaki’s repository exemplifies the innovative preclinical models that drive progress through collaboration and shared knowledge. We extend our deepest gratitude to her, Dr. Gutmann, the entire team at Washington University, and our generous community of supporters who make this life-changing research possible.

This kind of high-quality preclinical research is essential for progress.